Some interesting points. More later
1/ revenue likely in 27
2/some important info drops remain for 23, adoa and 4th drug(10B rev), the first is imminent.
3/efficacy readouts possible before 26 but very “uncertain” so many factors.
Ann: Q3 Investor Call 27 September 2023, page-12
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $559.9M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.5¢ | 12.0¢ | $1.019M | 8.456M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 326391 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 848396 | 7 |
View Market Depth
| Last trade - 10.47am 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
12.0¢ |
Change
0.000 ( 4.35 %) |
||||
| Open | High | Low | Volume | ||
| 12.5¢ | 12.5¢ | 11.5¢ | 1511297 | ||
| Last updated 11.12am 24/05/2024 ? | |||||
| PYC (ASX) Chart |